Titre : NADH, NADPH oxidoreductases

NADH, NADPH oxidoreductases : Questions médicales fréquentes

Termes MeSH sélectionnés :

Eye-Tracking Technology
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "NADH, NADPH oxidoreductases : Questions médicales les plus fréquentes", "headline": "NADH, NADPH oxidoreductases : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les NADH, NADPH oxidoreductases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-05", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "NADH, NADPH oxidoreductases" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Oxidoreductases", "url": "https://questionsmedicales.fr/mesh/D010088", "about": { "@type": "MedicalCondition", "name": "Oxidoreductases", "code": { "@type": "MedicalCode", "code": "D010088", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cytochrome reductases", "alternateName": "Cytochrome Reductases", "url": "https://questionsmedicales.fr/mesh/D003579", "about": { "@type": "MedicalCondition", "name": "Cytochrome reductases", "code": { "@type": "MedicalCode", "code": "D003579", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.608.191" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "NADPH-ferrihemoprotéine reductase", "alternateName": "NADPH-Ferrihemoprotein Reductase", "url": "https://questionsmedicales.fr/mesh/D009251", "about": { "@type": "MedicalCondition", "name": "NADPH-ferrihemoprotéine reductase", "code": { "@type": "MedicalCode", "code": "D009251", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.608.191.500" } } } ] }, { "@type": "MedicalWebPage", "name": "NADH tetrazolium reductase", "alternateName": "NADH Tetrazolium Reductase", "url": "https://questionsmedicales.fr/mesh/D009246", "about": { "@type": "MedicalCondition", "name": "NADH tetrazolium reductase", "code": { "@type": "MedicalCode", "code": "D009246", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.608.530" } } }, { "@type": "MedicalWebPage", "name": "NADP transhydrogenases", "alternateName": "NADP Transhydrogenases", "url": "https://questionsmedicales.fr/mesh/D009250", "about": { "@type": "MedicalCondition", "name": "NADP transhydrogenases", "code": { "@type": "MedicalCode", "code": "D009250", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.608.540" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "NADP transhydrogenase, AB-specific", "alternateName": "NADP Transhydrogenase, AB-Specific", "url": "https://questionsmedicales.fr/mesh/D061087", "about": { "@type": "MedicalCondition", "name": "NADP transhydrogenase, AB-specific", "code": { "@type": "MedicalCode", "code": "D061087", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.608.540.500" } } } ] }, { "@type": "MedicalWebPage", "name": "NADPH dehydrogenase", "alternateName": "NADPH Dehydrogenase", "url": "https://questionsmedicales.fr/mesh/D009252", "about": { "@type": "MedicalCondition", "name": "NADPH dehydrogenase", "code": { "@type": "MedicalCode", "code": "D009252", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.608.550" } } }, { "@type": "MedicalWebPage", "name": "Quinone reductases", "alternateName": "Quinone Reductases", "url": "https://questionsmedicales.fr/mesh/D011808", "about": { "@type": "MedicalCondition", "name": "Quinone reductases", "code": { "@type": "MedicalCode", "code": "D011808", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.608.800" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "NADPH dehydrogenase (quinone)", "alternateName": "NAD(P)H Dehydrogenase (Quinone)", "url": "https://questionsmedicales.fr/mesh/D016660", "about": { "@type": "MedicalCondition", "name": "NADPH dehydrogenase (quinone)", "code": { "@type": "MedicalCode", "code": "D016660", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.608.800.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "NADH, NADPH oxidoreductases", "alternateName": "NADH, NADPH Oxidoreductases", "code": { "@type": "MedicalCode", "code": "D009247", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Fei-Long Li", "url": "https://questionsmedicales.fr/author/Fei-Long%20Li", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, United Pharmaceutical Institute of Jiangsu University and Shandong Tianzhilvye Biotechnology Co. Ltd., Jiangsu University, Zhenjiang 212013, People's Republic of China." } }, { "@type": "Person", "name": "Ye-Wang Zhang", "url": "https://questionsmedicales.fr/author/Ye-Wang%20Zhang", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, United Pharmaceutical Institute of Jiangsu University and Shandong Tianzhilvye Biotechnology Co. Ltd., Jiangsu University, Zhenjiang 212013, People's Republic of China; College of Petroleum and Chemical Engineering, Beibu Gulf University, Qinzhou 535011, People's Republic of China. Electronic address: zhangyewang@ujs.edu.cn." } }, { "@type": "Person", "name": "Chuanwu Xia", "url": "https://questionsmedicales.fr/author/Chuanwu%20Xia", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, 53226, USA." } }, { "@type": "Person", "name": "Anna L Shen", "url": "https://questionsmedicales.fr/author/Anna%20L%20Shen", "affiliation": { "@type": "Organization", "name": "McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53706, USA." } }, { "@type": "Person", "name": "Jung-Ja P Kim", "url": "https://questionsmedicales.fr/author/Jung-Ja%20P%20Kim", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, 53226, USA. Electronic address: jjkim@mcw.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Reading performance in children with ADHD: an eye-tracking study.", "datePublished": "2022-08-03", "url": "https://questionsmedicales.fr/article/35920972", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11881-022-00269-x" } }, { "@type": "ScholarlyArticle", "name": "Eye tracking and eye expression decoding based on transparent, flexible and ultra-persistent electrostatic interface.", "datePublished": "2023-06-07", "url": "https://questionsmedicales.fr/article/37286541", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41467-023-39068-2" } }, { "@type": "ScholarlyArticle", "name": "Eyes on me: Investigating the role and influence of eye-tracking data on user modeling in virtual reality.", "datePublished": "2022-12-29", "url": "https://questionsmedicales.fr/article/36580442", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0278970" } }, { "@type": "ScholarlyArticle", "name": "Feasibility of self-reported health related quality of life assessment with older people in residential care: insights from the application of eye tracking technology.", "datePublished": "2023-07-20", "url": "https://questionsmedicales.fr/article/37474850", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11136-023-03488-w" } }, { "@type": "ScholarlyArticle", "name": "Eye-tracking during simulation-based echocardiography: a feasibility study.", "datePublished": "2023-07-01", "url": "https://questionsmedicales.fr/article/37393288", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12909-023-04458-z" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Oxidoreductases", "item": "https://questionsmedicales.fr/mesh/D010088" }, { "@type": "ListItem", "position": 5, "name": "NADH, NADPH oxidoreductases", "item": "https://questionsmedicales.fr/mesh/D009247" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : NADH, NADPH oxidoreductases - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur NADH, NADPH oxidoreductases", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur NADH, NADPH oxidoreductases", "description": "Comment diagnostiquer une déficience en NADH oxydoréductases ?\nQuels tests sanguins sont utiles pour évaluer NADPH ?\nQuels symptômes indiquent un problème avec ces enzymes ?\nLes tests d'activité enzymatique sont-ils fiables ?\nPeut-on détecter des anomalies génétiques liées à ces enzymes ?", "url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Eye-Tracking+Technology&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur NADH, NADPH oxidoreductases", "description": "Quels sont les symptômes d'une carence en NADH ?\nComment se manifeste une déficience en NADPH ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon l'âge ?\nDes symptômes digestifs peuvent-ils apparaître ?", "url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Eye-Tracking+Technology&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur NADH, NADPH oxidoreductases", "description": "Comment prévenir les déficiences en NADH ?\nY a-t-il des habitudes de vie à adopter ?\nLes bilans de santé réguliers sont-ils utiles ?\nLes vaccinations peuvent-elles jouer un rôle ?\nL'éducation nutritionnelle est-elle importante ?", "url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Eye-Tracking+Technology&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur NADH, NADPH oxidoreductases", "description": "Quels traitements existent pour les déficiences enzymatiques ?\nLa thérapie génique est-elle une option ?\nLes médicaments peuvent-ils aider à réguler ces enzymes ?\nY a-t-il des traitements naturels recommandés ?\nLes transfusions sanguines sont-elles nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Eye-Tracking+Technology&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur NADH, NADPH oxidoreductases", "description": "Quelles complications peuvent survenir avec une déficience en NADH ?\nLes infections sont-elles une complication fréquente ?\nY a-t-il des risques de maladies chroniques ?\nLes complications cardiovasculaires sont-elles possibles ?\nDes complications hématologiques peuvent-elles survenir ?", "url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Eye-Tracking+Technology&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur NADH, NADPH oxidoreductases", "description": "Quels facteurs de risque sont associés aux déficiences enzymatiques ?\nL'âge est-il un facteur de risque ?\nLe mode de vie influence-t-il le risque ?\nLes maladies génétiques sont-elles un facteur ?\nLe stress oxydatif joue-t-il un rôle ?", "url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Eye-Tracking+Technology&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en NADH oxydoréductases ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques et des analyses génétiques peuvent être utilisés pour diagnostiquer." } }, { "@type": "Question", "name": "Quels tests sanguins sont utiles pour évaluer NADPH ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les dosages de NADPH et d'autres coenzymes dans le sang peuvent être effectués." } }, { "@type": "Question", "name": "Quels symptômes indiquent un problème avec ces enzymes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, faiblesse musculaire et troubles métaboliques peuvent indiquer un problème." } }, { "@type": "Question", "name": "Les tests d'activité enzymatique sont-ils fiables ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont souvent utilisés pour évaluer la fonction des NADH et NADPH oxydoréductases." } }, { "@type": "Question", "name": "Peut-on détecter des anomalies génétiques liées à ces enzymes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests génétiques peuvent identifier des mutations affectant ces enzymes." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une carence en NADH ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, troubles cognitifs et faiblesse musculaire." } }, { "@type": "Question", "name": "Comment se manifeste une déficience en NADPH ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut se manifester par des infections fréquentes et des troubles métaboliques." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles neurologiques peuvent survenir en cas de dysfonctionnement enzymatique." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'âge et de l'état de santé général." } }, { "@type": "Question", "name": "Des symptômes digestifs peuvent-ils apparaître ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles digestifs peuvent être liés à des anomalies dans le métabolisme énergétique." } }, { "@type": "Question", "name": "Comment prévenir les déficiences en NADH ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée riche en nutriments essentiels peut aider à prévenir ces déficiences." } }, { "@type": "Question", "name": "Y a-t-il des habitudes de vie à adopter ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain incluant exercice et gestion du stress est recommandé." } }, { "@type": "Question", "name": "Les bilans de santé réguliers sont-ils utiles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des bilans réguliers peuvent aider à détecter précocement des anomalies enzymatiques." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles jouer un rôle ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent prévenir des infections qui aggravent les déficiences." } }, { "@type": "Question", "name": "L'éducation nutritionnelle est-elle importante ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, comprendre l'importance des nutriments peut aider à prévenir les carences." } }, { "@type": "Question", "name": "Quels traitements existent pour les déficiences enzymatiques ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent inclure des suppléments enzymatiques et des modifications diététiques." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie génique est explorée pour traiter certaines déficiences enzymatiques." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à réguler ces enzymes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent aider à moduler l'activité des NADH et NADPH oxydoréductases." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels recommandés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des antioxydants et des nutriments peuvent soutenir la fonction enzymatique." } }, { "@type": "Question", "name": "Les transfusions sanguines sont-elles nécessaires ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas graves, des transfusions peuvent être nécessaires pour corriger des déficiences." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une déficience en NADH ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles métaboliques graves et des problèmes neurologiques." } }, { "@type": "Question", "name": "Les infections sont-elles une complication fréquente ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes avec des déficiences enzymatiques sont plus susceptibles aux infections." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies chroniques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déficiences peuvent augmenter le risque de maladies chroniques comme le diabète." } }, { "@type": "Question", "name": "Les complications cardiovasculaires sont-elles possibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles métaboliques peuvent entraîner des complications cardiovasculaires." } }, { "@type": "Question", "name": "Des complications hématologiques peuvent-elles survenir ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans le métabolisme peuvent entraîner des complications hématologiques." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés aux déficiences enzymatiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des maladies métaboliques et une mauvaise nutrition." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines déficiences peuvent être plus fréquentes chez les personnes âgées." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque." } }, { "@type": "Question", "name": "Les maladies génétiques sont-elles un facteur ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies génétiques prédisposent aux déficiences en NADH et NADPH." } }, { "@type": "Question", "name": "Le stress oxydatif joue-t-il un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress oxydatif peut aggraver les déficiences enzymatiques et leurs effets." } } ] } ] }

Sources (10000 au total)

Feasibility of self-reported health related quality of life assessment with older people in residential care: insights from the application of eye tracking technology.

Increasingly there are calls to routinely assess the health-related quality of life (HRQoL) of older people receiving aged care services, however the high prevalence of dementia and cognitive impairme... Residents (n = 41), recruited based on one of three cognition subgroups (no, mild, or moderate cognitive impairment), completed the EQ-5D-5L on a computer with eye tracking technology embedded. Number... For all dimensions, participants with no cognitive impairment fixated for longer on the Area of Interest (AOI) for the response option they finally chose, relative to those with mild or moderate cogni... This exploratory study applying eye tracking technology provides novel insights and evidence of the feasibility of self-reported HRQoL assessments in older people in aged care settings where cognitive...

Eye-tracking during simulation-based echocardiography: a feasibility study.

Due to the technical progress point-of-care ultrasound (POCUS) is increasingly used in critical care medicine. However, optimal training strategies and support for novices have not been thoroughly res... Nine experts in echocardiography and six non-experts were equipped with eye-tracking glasses (Tobii, Stockholm, Sweden), while performing six medical cases on a simulator. For each view case specific ... Technical feasibility of eye-tracking during echocardiography was achieved with an accordance of 96% between the visual area orally described by participants and the area marked by the glasses. Expert... This feasibility study demonstrates that eye-tracking can be used to analyze experts and non-experts gaze patterns during POCUS. Although, in this study the experts had a longer fixation time in the d...

An investigation of privacy preservation in deep learning-based eye-tracking.

The expanding usage of complex machine learning methods such as deep learning has led to an explosion in human activity recognition, particularly applied to health. However, complex models which handl... A previously published deep learning model, trained to estimate the gaze from full-face image sequences was stress tested for personal information leakage by a white box inference attack. Full-face vi... The inference attack method and associated mathematical analysis indicate that there is a low likelihood of unintended memorization of facial features in the deep learning model.... In this study, it is showed that the named model preserves the integrity of training data with reasonable confidence. The same process can be implemented in similar conditions for different models....